SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-102230
Filing Date
2005-05-10
Accepted
2005-05-10 11:51:26
Documents
8
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2005 d10q.htm 10-Q 413000
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9730
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9725
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3785
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3788
6 PRESS RELEASE dex991.htm EX-99.1 50324
7 GRAPHIC g28664image_000.jpg GRAPHIC 18497
8 GRAPHIC g28664image_002.jpg GRAPHIC 2819
  Complete submission text file 0001193125-05-102230.txt   521419
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 05814738
SIC: 2834 Pharmaceutical Preparations